Intravitreal Ranibizumab Injection in Peripapillary CNVM Related to Idiopathic Intracranial Hypertension
Authors:
- Rana Altan-YayciogluRARana Altan-Yaycioglu
- Handan CananHCHandan Canan
- Semra SaygiSSSemra Saygi
- 1 November 2017
- journal article
- case report
- Published by SLACK, Inc. in Journal of Pediatric Ophthalmology & Strabismus
- Vol. 54 (6) , e27-e30
Abstract
Peripapillary choroidal neovascular membrane (CNVM) may develop in papilledema related to idiopathic intracranial hypertension. The authors present a teenaged boy who responded well to one dose of intravitreal ranibizumab injection. [ J Pediatr Ophthalmol Strabismus. 2017;54:e27–e30.]Keywords
This publication has 7 references indexed in Scilit:
- Intravitreal Bevacizumab in the Treatment of Peripapillary Choroidal Neovascular Membrane Secondary to Idiopathic Intracranial HypertensionJournal of Neuro-Ophthalmology, 2013
- Peripapillary Choroidal Neovascular Membrane in a Teenage BoyJournal of Neuro-Ophthalmology, 2013
- FUNCTIONAL RECOVERY AFTER INTRAVITREAL BEVACIZUMAB TREATMENTS FOR IDIOPATHIC CHOROIDAL NEOVASCULARIZATION IN YOUNG ADULTSRetina, 2012
- Peripapillary neovascular membrane: A rare cause of acute vision loss in pediatric idiopathic intracranial hypertensionJournal of American Association for Pediatric Ophthalmology and Strabismus, 2011
- Intravitreal bevacizumab for the treatment of choroidal neovascularization secondary to pseudotumor cerebriInternational Ophthalmology, 2008
- Subretinal Neovascular Membrane in Idiopathic Intracranial HypertensionAmerican Journal of Ophthalmology, 2006
- Bilateral Juxtapapillary Subretinal Neovascularization Associated with Pseudotumor CerebriAmerican Journal of Ophthalmology, 1981